Schizophrenia News and Research

Latest Schizophrenia News and Research

Internet program helps reduce depressive symptoms in teens

An Internet program helps to reduce depressive symptoms and prevent episodes of clinical depression in adolescent patients at risk, reports a study in the February issue of the Journal of Developmental & Behavioral Pediatrics.

2 Feb 2009

Discovery of brain's memory 'buffer' in single cells

Individual nerve cells in the front part of the brain can hold traces of memories on their own for as long as a minute and possibly longer, researchers at UT Southwestern Medical Center have found.

27 Jan 2009

Dynamical theory and novel 4-D colorimetric method reveal modus operandi of intact living brain

For the brain to achieve its intricate functions such as perception, action, attention and decision making, neural regions have to work together yet still retain their specialized roles.

21 Jan 2009

New findings on schizophrenia

Schizophrenia may blur the boundary between internal and external realities by overactivating a brain system that is involved in self-reflection, and thus causing an exaggerated focus on self, a new MIT and Harvard brain imaging study has found.

21 Jan 2009

Schizophrenia and bipolar disorder have same genetic causes

Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.

21 Jan 2009

Altered brain activity in schizophrenia may direct focus on self

19 Jan 2009

Lack of grey matter linked to schizophrenia and bipolar disorder

A research study led by scientists from the Gregorio Marañón University Hospital in Madrid and the Network of Centres for Biomedical Research in Mental Health Networks (CIBERSAM) shows that adolescents experiencing a first outbreak of psychosis have lower levels of grey matter in their brains than healthy teenagers. Strangely, this change was seen in patients suffering from various psychoses, including bipolar illness and schizophrenia.

19 Jan 2009

Eli Lilly to pay $1.415 billion for off-label promotion of Zyprexa

American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA), the Department of Justice announced today.

19 Jan 2009

FDA issues complete response letter for SAPHRIS (asenapine) sublingual tablets in acute treatment of schizophrenia and bipolar disorder

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy.

15 Jan 2009

Even small amounts of exercise good for people with serious mental illnesses

A new study from Indiana University suggests that even meager levels of physical activity can improve the mood of people with serious mental illnesses (SMI) such as bipolar disorder, major depression and schizophrenia.

15 Jan 2009

Genetic variation cues social anxiety in monkeys and humans

A genetic variation involving the brain chemical serotonin has been found to shape the social behavior of rhesus macaque monkeys, which could provide researchers with a new model for studying autism, social anxiety and schizophrenia.

15 Jan 2009

Researchers study asymmetry in the brain

A tug-of-war between the two sides of the brain causes it to become asymmetrical, according to research published today in the journal Neuron.

15 Jan 2009

Delusions associated with consistent pattern of brain injury

A new study provides a novel theory for how delusions arise and why they persist.

13 Jan 2009

Missing DNA the culprit in epilepsy?

An international team of scientists have identified a genetic risk factor for epilepsy which may lead to a better understanding of what causes the seizures and the development of new treatments for the condition.

12 Jan 2009

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.

7 Jan 2009

Study looks at brain and movement planning

When you first notice a door handle, your brain has already been hard at work. Your visual system first sees the handle, then it sends information to various parts of the brain, which go on to decipher out the details, such as color and the direction the handle is pointing. As the information about an object is sent further along the various brain pathways, more and more details are noticed-in that way, a simple door handle turns into a silver-plated-antique-style-door-handle-facing-right.

18 Dec 2008

Schizophrenia and autism may share common origin

Schizophrenia and autism probably share a common origin, hypothesises Dutch researcher Annemie Ploeger following an extensive literature study.

17 Dec 2008

Borderline personality disorder more common than schizophrenia

According to the National Institute of Mental Health, borderline personality disorder (BPD) is more common than schizophrenia or bipolar disorder and is estimated to affect 2 percent of the population.

16 Dec 2008

Study looks at how parental age affects the mental functioning of offspring

Tel Aviv University researchers found in several consecutive studies that older dads are more likely to have boys with autism and lower IQs. Most recently, they found that the older a father's age, the greater the chance that his son will display poor social abilities as a teen.

15 Dec 2008

Paliperidone palmitate shows positive results for treatment of schizophrenia

Paliperidone palmitate, an investigational long-acting therapy (LAT) demonstrated statistically significant symptom control compared with placebo according to the results of a 13-week study.

14 Dec 2008